Literature DB >> 2559171

Molecular biology and pathophysiology of the intrarenal renin-angiotensin system.

V J Dzau1, J R Ingelfinger.   

Abstract

There has been considerable interest in the existence of an intrarenal renin-angiotensin system and its physiological implications. Recent demonstrations of renin, angiotensinogen and angiotensin converting enzyme messenger (m)RNAs in the kidney have provided strong evidence for the presence of an independent local system. This has been further supported by the demonstration of tissue-specific regulation of renin and angiotensinogen mRNA expression which may lead to differential systemic and intrarenal angiotensin activities. Using in situ hybridization, we have localized the intrarenal sites of gene expression and possible angiotensin production. One major site appears to be the proximal tubule, where local angiotensin can regulate sodium reabsorption and urine pH. Renin and angiotensinogen mRNA expressions are regulated by several common factors. In particular, sodium depletion stimulates the expression of both genes in the kidney, increasing the production of intrarenal angiotensin that is important in maintaining sodium homeostasis. Renal renin and angiotensinogen mRNA levels are altered in experimental heart failure and the spontaneously hypertensive rat (SHR). These changes in intrarenal renin and angiotensinogen mRNA expression may be important in the renal pathophysiology of these diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2559171     DOI: 10.1097/00004872-198909007-00002

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  8 in total

Review 1.  Catecholamines and angiotensinogen gene expression in kidney proximal tubular cells.

Authors:  J S Chan; T T Wang; S L Zhang; X Chen; S Carrière
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 2.  Non-steroidal anti-inflammatory drugs and angiotensin converting enzyme inhibitors: a commonly prescribed combination with variable effects on renal function.

Authors:  N D Sturrock; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

3.  Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice.

Authors:  S Abdo; C-S Lo; I Chenier; A Shamsuyarova; J G Filep; J R Ingelfinger; S-L Zhang; J S D Chan
Journal:  Diabetologia       Date:  2013-04-23       Impact factor: 10.122

4.  Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney.

Authors:  L K Lee; T W Meyer; A S Pollock; D H Lovett
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

5.  Overexpression of angiotensinogen increases tubular apoptosis in diabetes.

Authors:  Fang Liu; Marie-Luise Brezniceanu; Chih-Chang Wei; Isabelle Chénier; Sébastien Sachetelli; Shao-Ling Zhang; Janos G Filep; Julie R Ingelfinger; John S D Chan
Journal:  J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 10.121

6.  Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice.

Authors:  Chao-Sheng Lo; Shiao-Ying Chang; Isabelle Chenier; Janos G Filep; Julie R Ingelfinger; Shao Ling Zhang; John S D Chan
Journal:  Diabetes       Date:  2012-06-04       Impact factor: 9.461

7.  Insulin Inhibits Nrf2 Gene Expression via Heterogeneous Nuclear Ribonucleoprotein F/K in Diabetic Mice.

Authors:  Anindya Ghosh; Shaaban Abdo; Shuiling Zhao; Chin-Han Wu; Yixuan Shi; Chao-Sheng Lo; Isabelle Chenier; Thierry Alquier; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Endocrinology       Date:  2017-04-01       Impact factor: 4.736

8.  Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice.

Authors:  Shaaban Abdo; Yixuan Shi; Abouzar Otoukesh; Anindya Ghosh; Chao-Sheng Lo; Isabelle Chenier; Janos G Filep; Julie R Ingelfinger; Shao Ling Zhang; John S D Chan
Journal:  Diabetes       Date:  2014-05-08       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.